PeptideComparePinealon — EU research guide.
Pinealon (Glu-Asp-Arg) is a synthetic tripeptide bioregulator targeting pineal gland and brain tissue. It is studied for circadian rhythm support, neuroprotection and sleep quality in Russian gerontological research.
What is Pinealon?
Pinealon is a short-sequence bioregulator from the Khavinson peptide series. It is proposed to target pineal gland and neuronal tissue, modulating expression of genes involved in melatonin synthesis and circadian regulation. The tripeptide structure allows cell penetration and proposed interaction with nucleosomal DNA.
What does the research show?
Russian preclinical studies report neuroprotective effects in oxidative stress models, improved spatial memory in aged rats, and melatonin pathway modulation. Some human observational studies in elderly cohorts suggest improved sleep quality metrics. Evidence is limited to Russian-language literature and small studies without placebo-controlled replication in Western journals.
EU legal status
Not approved as a medicine in the EU. Available from specialist EU research vendors as a laboratory compound for neuroscience research.
Molecular information
Pharmacokinetics
Potency retained over time
Each line is one storage condition: it starts at 100% and falls as potency is lost. Above the dashed 80% line the material is considered reliable — hover for exact values.
⚠ Modelled per compound from molecular structure — chain length, cyclisation, oxidation- and deamidation-prone residues and light sensitivity. Indicative only, not lab-measured per batch.
Pinealon across EU suppliers
COA-verified EU vendors · Updated monthly